PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET ANALYSIS
Global Pediatric Interventional Cardiology Market: Key Developments
In September 2022, The U.S. Food and Drug Administration (FDA) has granted the first pediatric indication for an implantable cardiac monitor to Medtronic. The Linq II Insertable Cardiac Monitor (ICM) system is the first such device to receive 510(k) clearance for use in pediatric patients over the age of 2 who have heart rhythm abnormalities and require long-term, continuous monitoring.
In May 2019, B. Braun Interventional announced the launch of NuDEL all-in-one stent delivery system. The NuDEL CP Stent Delivery System is developed in collaboration with NuMED Inc. to treat congenital heart defects.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :